{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:45:31Z","timestamp":1747161931116,"version":"3.40.5"},"reference-count":7,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ijcard.2014.07.146","type":"journal-article","created":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T02:00:50Z","timestamp":1407117650000},"page":"1334-1335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rates of aldosterone antagonist use after myocardial infarction remain poor over time among guideline eligible patients"],"prefix":"10.1016","volume":"176","author":[{"given":"Houman","family":"Khalili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5065-457X","authenticated-orcid":false,"given":"Anthony","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"de Lemos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep R.","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2014.07.146_bb0005","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2014.07.146_bb0010","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1161\/CIR.0b013e3182742c84","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"O'Gara","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2014.07.146_bb0015","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1161\/CIRCULATIONAHA.107.181940","article-title":"ACC\/AHA 2007 guidelines for the management of patients with unstable angina\/non ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"116","author":"Anderson","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2014.07.146_bb0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jacc.2012.08.1019","article-title":"Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction","volume":"61","author":"Rassi","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2014.07.146_bb0025","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ahj.2013.06.020","article-title":"Use of aldosterone antagonists at discharge after myocardial infarction: results from the national cardiovascular data registry acute coronary treatment and intervention outcomes network (ACTION) registry-get with the guidelines (GWTG)","volume":"166","author":"Rao","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2014.07.146_bb0030","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1161\/CIRCULATIONAHA.108.191099","article-title":"ACC\/AHA 2008 performance measures for adults with st-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures","volume":"118","author":"Krumholz","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2014.07.146_bb0035","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/eurjhf\/hfp136","article-title":"Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial","volume":"11","author":"Adamopoulos","year":"2009","journal-title":"Eur J Heart Fail"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314013564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314013564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T01:31:22Z","timestamp":1538357482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527314013564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0167527314013564"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.07.146","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rates of aldosterone antagonist use after myocardial infarction remain poor over time among guideline eligible patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.07.146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}